The development of a screening questionnaire to improve the early detection of pulmonary arterial hypertension

Objective: development of a questionnaire for the early detection of pulmonary arterial hypertension (PAH), and its further introduction for a broad routine medical practice.Were identified clinical symptoms, allowing differentiate various forms of the disease (IPAH and PAH-CHD), because these forms of PAH most frequent in cardiology practice.Material and methods. The questionnaire includes 6 sections: clinical symptoms, physical examination, anamnestic information, diseases associated with pulmonary hypertension; signs of PAH according to electrocardiography, chest radiography, echocardiography. All sections of the questionnaire filled by physician. Was held a retrospective analysis of the clinical symptoms, physical examination, anamnestic information, methods of instrumental examination of 70 patients with IPAH in comparison with 29 patients with PAH-CHD and the control group - 48 patients with arterial hypertension (AH).Results. The leading complaints in patients with PAH are dyspnea (99%), palpitations (58%), fatigue (59%), syncope (21%), dry cough (28%), peripheral edema (38%). The physical signs of PAH include an accentuated pulmonary component of second heart sound (93%), cyanosis (40%). Most often, the development of pulmonary hypertension precipitated by stress, pregnancy, acute respiratory infections.Conclusion. According to the results we concluded that the developed questionnaire may be offered for wide use in routine clinical practice and recommended not only for screening patients with IPAH, but also with PAH-CHD.

pulmonary arterial hypertension, idiopathic pulmonary hypertension, the questionnaire for pulmonary hypertension

1. Российские рекомендации по диагностике и лечению легочной гипертензии. 2007.

2. Guidelines for the diagnosis and treatment of pulmonary hypertension. The task force for the diagnosis and treatment of pulmonary hypertension of the ECS and ERS, endorsed by the ISHLT. Eur Heart J 2009; 30: 2493-537.

3. Simonneau G, Gatzoulis M.A, Ian Adatia I et al. Updated Clinical Classification of Pulmonary Hypertension. J Am Coll Cardiol 2013; 62 (25, Suppl.): 34-41.

4. Brown L.M, Chen H, Halpern S.M et al. Delay in recognition of pulmonary aretrial hypertension: factors identified from the REVEAL registry. Chest 2011; 140: 19-26.

5. Humbert M, Sitbon O, Chaouat A et al. Pulmonary arterial hypertension in France: results from a national registry. Am J Respir Crit Care Med 2006; 173: 1023-30.

6. Мартынюк Т.В. Идиопатическая легочная гипертензия: клинико - патофизиологические особенности и возможности патогенетически обоснованной терапии. Автореф. дис. ... д - ра мед. наук. М., 2013.

7. Rich S, Dantzker R, Ayres S et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med 1987; 107: 216-23.

8. Беленков Ю.Н., Чазова И.Е. Первичная легочная гипертензия. М.: Нолидж, 1991.

9. Mc Goon M, Gutterman D, Steen V, Barst R et al. Screening, early detection and diagnosis of pulmonary arterial hypertension. Chest 2004; 126: 14S-34S.

10. Soto F.J et al. Performance of pulmonary capillary wedge pressure (PCWP) vs. left ventricular end diastolic pressure (LVEDP) in the diagnosis and classification of patients with suspect pulmonary arterial hypertension (PAH). Chest 2005; 128 (Suppl): 137S.

11. Hoeper M, Barbera J.A, Channick R et al. Diagnosis, assessment, and treatment of non-PAH pulmonary hypertension. J Am Coll Cardiol 2009; 54: S85-S96.

12. Mc Laughlin V.V, Presberg K.W, Doyle R.L et al. Prognosis of pulmonary arterial hypertension ACCP evidence - based clinical practice guidelines. Chest 2004; 126:78S-92S.

13. Rich S, Dantzker R, Ayres S et al. Primary pulmonary hypertension: a national prospective study. Ann Intern Med 1987; 107: 216-23.

14. Чазова И.Е., Архипова О.А., Валиева З.С. и др. Легочная гипертензия в России: первые результаты национального регистра. Терапевт. арх. 2014; 9: 56-64.

15. Fishman A.P. State of the art: chronic cor pulmonale. Am Rev Respir Dis 1976; 114: 775-94.

16. Galie N, Torbicki A, Barst R et al. the Task Force on Diagnosis and Treatment of Pulmonary Arterial Hypertension of the European Society of Cardiology. Guidelines on Diagnosis and Treatment of Pulmonary Arterial Hypertension. Eur Heart J 2004; 25: 2243-78.